{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T20:02:58Z","timestamp":1780430578431,"version":"3.54.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ogc.2026.01.005","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T21:43:26Z","timestamp":1772228606000},"page":"339-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expanding Access to Cervical Cancer Screening for Transgender and Nonbinary Individuals"],"prefix":"10.1016","volume":"53","author":[{"given":"Emma Chew","family":"Murphy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tami S.","family":"Rowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ogc.2026.01.005_bib1","series-title":"Cancers caused by HPV","year":"2025"},{"issue":"33","key":"10.1016\/j.ogc.2026.01.005_bib2","doi-asserted-by":"crossref","first-page":"724","DOI":"10.15585\/mmwr.mm6833a3","article-title":"Human papillomavirus-attributable cancers - united States, 2012-2016","volume":"68","author":"Senkomago","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"16","key":"10.1016\/j.ogc.2026.01.005_bib3","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1007\/s11606-024-09026-9","article-title":"Strategies to optimize cervical cancer screening rates among transgender and gender-diverse people assigned female at birth","volume":"39","author":"Fosmore","year":"2024","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ogc.2026.01.005_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2020.106071","article-title":"Barriers and facilitators to cervical cancer screening among transgender men and non-binary people with a cervix: a systematic narrative review","volume":"135","author":"Connolly","year":"2020","journal-title":"Prev Med (Baltim)"},{"issue":"5","key":"10.1016\/j.ogc.2026.01.005_bib5","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/1471-0528.16503","article-title":"Cervical cancer prevention in transgender men: a review","volume":"128","author":"Weyers","year":"2021","journal-title":"BJOG"},{"key":"10.1016\/j.ogc.2026.01.005_bib6","article-title":"Qualitative socioecological factors of cervical cancer screening use among transgender men","volume":"17","author":"Johnson","year":"2020","journal-title":"Prev Med Rep"},{"key":"10.1016\/j.ogc.2026.01.005_bib7","unstructured":"Rastogi A, Menard L, Miller GH, et al. Health and wellbeing: a report of the 2022 U.S. Transgender Survey; 2025."},{"issue":"3","key":"10.1016\/j.ogc.2026.01.005_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190172","article-title":"Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients","volume":"13","author":"Reisner","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ogc.2026.01.005_bib9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/cyt.13199","article-title":"Clinical history of female-to-male transgender patients is needed to avoid misinterpretation of cervical papanicolaou tests","volume":"34","author":"Moatamed","year":"2023","journal-title":"Cytopathology"},{"issue":"11","key":"10.1016\/j.ogc.2026.01.005_bib10","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/dc.25030","article-title":"Cervicovaginal cytology, HPV testing and vaginal flora in transmasculine persons receiving testosterone","volume":"50","author":"Lin","year":"2022","journal-title":"Diagn Cytopathol"},{"issue":"3","key":"10.1016\/j.ogc.2026.01.005_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/cyt.12525","article-title":"Characteristic findings of cervical papanicolaou tests from transgender patients on androgen therapy: challenges in detecting dysplasia","volume":"29","author":"Adkins","year":"2018","journal-title":"Cytopathology"},{"issue":"6","key":"10.1016\/j.ogc.2026.01.005_bib12","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.21037\/tau-20-954","article-title":"Cancer screening in the transgender population: a review of current guidelines, best practices, and a proposed care model","volume":"9","author":"Sterling","year":"2020","journal-title":"Transl Androl Urol"},{"issue":"7","key":"10.1016\/j.ogc.2026.01.005_bib13","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1089\/lgbt.2023.0418","article-title":"Gender-affirming hormone therapy and cervical cancer screening rates in transgender men and nonbinary people: a cross-sectional study from a Boston community health center","volume":"11","author":"Fleming","year":"2024","journal-title":"LGBT Health"},{"issue":"1","key":"10.1016\/j.ogc.2026.01.005_bib14","first-page":"e30","article-title":"Cancer screening rates among transgender adults: cross-sectional analysis of primary care data","volume":"65","author":"Kiran","year":"2019","journal-title":"Can Fam Physician"},{"issue":"6","key":"10.1016\/j.ogc.2026.01.005_bib15","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.amepre.2014.07.031","article-title":"Pap test use is lower among female-to-male patients than non-transgender women","volume":"47","author":"Peitzmeier","year":"2014","journal-title":"Am J Prev Med"},{"issue":"5","key":"10.1016\/j.ogc.2026.01.005_bib16","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s11606-013-2753-1","article-title":"Female-to-male patients have high prevalence of unsatisfactory paps compared to non-transgender females: implications for cervical cancer screening","volume":"29","author":"Peitzmeier","year":"2014","journal-title":"J Gen Intern Med"},{"issue":"6","key":"10.1016\/j.ogc.2026.01.005_bib17","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1111\/jocn.17023","article-title":"Transgender and non-binary peoples experiences of cervical cancer screening: a scoping review","volume":"33","author":"Rivers","year":"2024","journal-title":"J Clin Nurs"},{"issue":"1","key":"10.1016\/j.ogc.2026.01.005_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1089\/trgh.2018.0022","article-title":"Motivators and barriers to accessing sexual health care services for transgender\/genderqueer individuals assigned female sex at birth","volume":"4","author":"Harb","year":"2019","journal-title":"Transgend Health"},{"issue":"14","key":"10.1016\/j.ogc.2026.01.005_bib19","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1177\/1049732317725513","article-title":"\u201cIt can promote an existential crisis\u201d: factors influencing pap test acceptability and utilization among transmasculine individuals","volume":"27","author":"Peitzmeier","year":"2017","journal-title":"Qual Health Res"},{"issue":"12","key":"10.1016\/j.ogc.2026.01.005_bib20","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1007\/s11606-015-3462-8","article-title":"Cervical cancer screening for patients on the female-to-male spectrum: a narrative review and guide for clinicians","volume":"30","author":"Potter","year":"2015","journal-title":"J Gen Intern Med"},{"issue":"709","key":"10.1016\/j.ogc.2026.01.005_bib21","doi-asserted-by":"crossref","first-page":"e614","DOI":"10.3399\/BJGP.2020.0905","article-title":"Attitudes of transgender men and non-binary people to cervical screening: a cross-sectional mixed-methods study in the UK","volume":"71","author":"Berner","year":"2021","journal-title":"Br J Gen Pract"},{"issue":"5","key":"10.1016\/j.ogc.2026.01.005_bib22","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/AOG.0000000000003816","article-title":"The imperative for transgender and gender nonbinary inclusion: beyond women\u2019s health","volume":"135","author":"Moseson","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ogc.2026.01.005_bib23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/23293691.2022.2094737","article-title":"\u201cDoing it on my own terms\u201d: Transgender and nonbinary adults\u2019 experiences with HPV self-swabbing home testing kits","volume":"10","author":"Kattari","year":"2023","journal-title":"Womens Reprod Health (Phila)"},{"issue":"sup1","key":"10.1016\/j.ogc.2026.01.005_bib24","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","article-title":"Standards of care for the health of transgender and gender diverse people, version 8","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgend Health"},{"issue":"5","key":"10.1016\/j.ogc.2026.01.005_bib25","first-page":"321","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American cancer Society","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.ogc.2026.01.005_bib26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/LGT.0000000000000763","article-title":"Understanding sexual and gender minority populations and organ-based screening recommendations for human papillomavirus-related cancers","volume":"27","author":"Jodry","year":"2023","journal-title":"J Low Genit Tract Dis"},{"issue":"3","key":"10.1016\/j.ogc.2026.01.005_bib27","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/AOG.0000000000004296","article-title":"Health care for transgender and gender diverse individuals: ACOG committee opinion summary, number 823","volume":"137","year":"2021","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.ogc.2026.01.005_bib28","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US preventive services task force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.ogc.2026.01.005_bib29","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1001\/jama.2021.15731","article-title":"USPSTF approach to addressing sex and gender when making recommendations for clinical preventive services","volume":"326","author":"Caughey","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ogc.2026.01.005_bib30","series-title":"Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people; 2nd Edition.UCSF gender affirming health Program, department of family and community medicine","article-title":"Screening for cervical cancer in transgender men","author":"Hsiao","year":"2016"},{"issue":"2","key":"10.1016\/j.ogc.2026.01.005_bib31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"issue":"8","key":"10.1016\/j.ogc.2026.01.005_bib32","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/jcp.56.8.592","article-title":"Outcome of women with inadequate cervical smears followed up for five years","volume":"56","author":"Hock","year":"2003","journal-title":"J Clin Pathol"},{"issue":"2","key":"10.1016\/j.ogc.2026.01.005_bib33","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1258\/096914104774061047","article-title":"CIN 2\/3 and cervical cancer in an organised screening programme after an unsatisfactory or a normal pap smear: a seven-year prospective study of the Norwegian population-based screening programme","volume":"11","author":"Nyg\u00e5rd","year":"2004","journal-title":"J Med Screen"},{"issue":"9","key":"10.1016\/j.ogc.2026.01.005_bib34","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/cncy.21443","article-title":"Factors associated with reduced accuracy in papanicolaou tests for patients with invasive cervical cancer","volume":"122","author":"Zhao","year":"2014","journal-title":"Cancer Cytopathol"},{"issue":"11","key":"10.1016\/j.ogc.2026.01.005_bib35","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1038\/sj.bjc.6602224","article-title":"Psychological costs of inadequate cervical smear test results","volume":"91","author":"French","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ogc.2026.01.005_bib36","unstructured":"James SE, Herman JL, Rankin S, et al. The Report of the 2015 U.S. Transgender Survey. 2016."},{"issue":"5","key":"10.1016\/j.ogc.2026.01.005_bib37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/ijir.2013.9","article-title":"Effects of long-term high dose testosterone administration on vaginal epithelium structure and estrogen receptor-\u03b1 and -\u03b2 expression of young women","volume":"25","author":"Baldassarre","year":"2013","journal-title":"Int J Impot Res"},{"issue":"10","key":"10.1016\/j.ogc.2026.01.005_bib38","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1080\/13691058.2016.1177203","article-title":"Perceptions of cervical cancer risk and screening among transmasculine individuals: patient and provider perspectives","volume":"18","author":"Ag\u00e9nor","year":"2016","journal-title":"Cult Health Sex"},{"issue":"6","key":"10.1016\/j.ogc.2026.01.005_bib39","doi-asserted-by":"crossref","first-page":"742","DOI":"10.5858\/arpa.2021-0199-OA","article-title":"Histologic findings in gynecologic tissue from transmasculine individuals undergoing gender-affirming surgery","volume":"146","author":"Lin","year":"2022","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.ogc.2026.01.005_bib40","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/PGP.0000000000000548","article-title":"Histologic features of hysterectomy specimens from female-male transgender individuals","volume":"38","author":"Khalifa","year":"2019","journal-title":"Int J Gynecol Pathol"},{"issue":"7","key":"10.1016\/j.ogc.2026.01.005_bib41","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/cncy.22259","article-title":"Cytomorphologic findings of cervical pap smears from female-to-male transgender patients on testosterone therapy","volume":"128","author":"Williams","year":"2020","journal-title":"Cancer Cytopathol"},{"issue":"2","key":"10.1016\/j.ogc.2026.01.005_bib42","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3892\/ol.2015.4071","article-title":"Efficacy of p16 and Ki-67 immunostaining in the detection of squamous intraepithelial lesions in a high-risk HPV group","volume":"11","author":"Lim","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ogc.2026.01.005_bib43","series-title":"WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention","year":"2015"},{"issue":"4","key":"10.1016\/j.ogc.2026.01.005_bib45","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1089\/lgbt.2016.0187","article-title":"Cervical cancer screening preferences among trans-masculine individuals: patient-collected human papillomavirus vaginal swabs versus provider-administered pap tests","volume":"4","author":"McDowell","year":"2017","journal-title":"LGBT Health"},{"key":"10.1016\/j.ogc.2026.01.005_bib46","doi-asserted-by":"crossref","DOI":"10.1089\/lgbt.2023.0336","article-title":"Cervicovaginal and anal self-sampling for human papillomavirus testing in a transgender and gender diverse population assigned female at birth: comfort, difficulty, and willingness to use","author":"Welsh","year":"2024","journal-title":"LGBT Health"},{"issue":"2","key":"10.1016\/j.ogc.2026.01.005_bib47","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/LGT.0000000000000885","article-title":"Self-collected vaginal specimens for HPV testing: recommendations from the enduring consensus cervical Cancer Screening and Management Guidelines Committee","volume":"29","author":"Wentzensen","year":"2025","journal-title":"J Low Genit Tract Dis"},{"issue":"2","key":"10.1016\/j.ogc.2026.01.005_bib48","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/ijc.33967","article-title":"Meta-analysis of agreement\/concordance statistics in studies comparing self- vs clinician-collected samples for HPV testing in cervical cancer screening","volume":"151","author":"Arbyn","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ogc.2026.01.005_bib50","series-title":"Contraceptive technology conference","article-title":"Clinical pearls for sexual and reproductive care of transgender patients","author":"Lareau","year":"2025"},{"key":"10.1016\/j.ogc.2026.01.005_bib51","series-title":"Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people; 2nd Edition.CSF gender affirming health Program, department of family and community medicine","article-title":"Transgender patients and the physical examination","author":"Wesp","year":"2016"},{"issue":"1","key":"10.1016\/j.ogc.2026.01.005_bib52","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1089\/trgh.2018.0022","article-title":"Motivators and barriers to accessing sexual health care services for transgender\/genderqueer individuals assigned female sex at birth","volume":"4","author":"Harb","year":"2019","journal-title":"Transgend Health"},{"key":"10.1016\/j.ogc.2026.01.005_bib53","series-title":"Gay and Lesbian Medical Association","article-title":"If you have it, check it: overcoming barriers to cervical cancer screening with patients on the female-to-male transgender spectrum","author":"Bernstein","year":"2014"},{"issue":"3","key":"10.1016\/j.ogc.2026.01.005_bib54","doi-asserted-by":"crossref","DOI":"10.1177\/1557988320925691","article-title":"Bridging barriers to cervical cancer screening in transgender men: a scoping review","volume":"14","author":"Dhillon","year":"2020","journal-title":"Am J Mens Health"},{"key":"10.1016\/j.ogc.2026.01.005_bib55","author":"Rollston"},{"issue":"6","key":"10.1016\/j.ogc.2026.01.005_bib56","doi-asserted-by":"crossref","first-page":"669.e1","DOI":"10.1016\/j.ajog.2023.08.035","article-title":"Testosterone use and sexual function among transgender men and gender diverse people assigned female at birth","volume":"229","author":"Tordoff","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"32","key":"10.1016\/j.ogc.2026.01.005_bib57","doi-asserted-by":"crossref","first-page":"698","DOI":"10.15585\/mmwr.mm6832a3","article-title":"Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices","volume":"68","author":"Meites","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"10.1016\/j.ogc.2026.01.005_bib58","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/OLQ.0000000000000521","article-title":"The Association of Health Seeking Behaviors with human papillomavirus vaccination status among high-risk urban youth","volume":"43","author":"Fontenot","year":"2016","journal-title":"Sex Transm Dis"},{"issue":"4","key":"10.1016\/j.ogc.2026.01.005_bib59","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/15532739.2018.1470593","article-title":"Preventive healthcare services use among transgender young adults","volume":"19","author":"McRee","year":"2018","journal-title":"Int J Transgend"},{"issue":"4","key":"10.1016\/j.ogc.2026.01.005_bib60","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/trgh.2021.0077","article-title":"Gender-related health care discrimination and human papillomavirus vaccination among transgender and nonbinary young adults in the United States","volume":"8","author":"Ag\u00e9nor","year":"2023","journal-title":"Transgend Health"},{"issue":"4","key":"10.1016\/j.ogc.2026.01.005_bib62","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/trgh.2020.0174","article-title":"Human papillomavirus vaccination among transgender and gender diverse people in the United States: an integrative review","volume":"7","author":"Pho","year":"2022","journal-title":"Transgend Health"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854526000057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854526000057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:16:16Z","timestamp":1780427776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854526000057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0889854526000057"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2026.01.005","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expanding Access to Cervical Cancer Screening for Transgender and Nonbinary Individuals","name":"articletitle","label":"Article Title"},{"value":"Obstetrics and Gynecology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogc.2026.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}